Zum Inhalt springen

Blood test detects early Alzheimer’s with 90% accuracy, semaglutide shows cognitive benefits in trials

Semaglutide shows unexpected cognitive benefits in early trials

The Alzheimer’s Association International Conference in Chicago unveiled a blood test that detects early signs of Alzheimer’s with 90% accuracy, offering a less invasive alternative to spinal taps or brain scans. Neurology professor Christoph Kleinschnitz, who attended the congress, explained in BILDplus that the test measures phosphorylated tau proteins in blood plasma, which correlate strongly … Weiterlesen …